Watch CHE. Know when insiders buy.
One email the day a filing lands. Free.
Work order
13
FLAG · insiders 25, shorts 0
Insiders, 90 days
−$1.6M
net selling · 0 buys, 2 sells
Congress, 90 days
0 / 0
no disclosures naming it
Big money
0 / 15
none of the tracked funds disclose it
Calls on record
0
nobody we score has called it yet
MKT CAP $6.8BP/E 26.1DIV YIELD 0.46%FCF YIELD 4.76%REV TTM $2.6B +3.3%NET INCOME $275M −5.3%NET CASH $19M52W 368.59 – 552.72SEC XBRL · TTM TO Invalid Date
Financials
By quarter
| Period | Revenue | YoY | Gross margin | Operating income | Net income | YoY | EPS | Op. cash flow | Capex | Free cash flow | Filed |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Q2 2026 · Jun 30 | $673.3M | +8.8% | 32.9% | $89.2M | $67.7M | +29.0% | 5.13 | $84.8M | $15.5M | $69.3M | Jul 31 |
| Q1 2026 · Mar 31 | $657.5M | +1.6% | 32.8% | $84.6M | $66.3M | −7.6% | 4.84 | $88.2M | $17.1M | $71.1M | Apr 28 |
| Q4 2025 · Dec 31derived | $639.3M | −0.1% | 35.2% | $100.7M | $76.8M | −15.0% | 5.45 | $133.5M | $16.3M | $117.2M | Feb 27 |
| Q3 2025 · Sep 30 | $624.9M | +3.1% | 31.5% | $74.8M | $64.2M | −15.2% | 4.46 | $83.4M | $17.5M | $65.9M | Oct 31 |
| Q2 2025 · Jun 30 | $618.8M | +3.8% | 29.8% | $68.1M | $52.5M | −25.9% | 3.57 | $138.6M | $15.8M | $122.8M | Jul 31 |
| Q1 2025 · Mar 31 | $646.9M | +9.8% | 33.5% | $94.8M | $71.8M | +10.4% | 4.86 | $32.7M | $13.3M | $19.5M | Apr 28 |
| Q4 2024 · Dec 31derived | $640M | +9.2% | 36.6% | $113.9M | $90.3M | +0.3% | 6.01 | $164.9M | $12.8M | $152.2M | Feb 27 |
| Q3 2024 · Sep 30 | $606.2M | +7.4% | 34.6% | $92.2M | $75.8M | +1.1% | 5.00 | $90.5M | $18.6M | $71.9M | Oct 31 |
| Q2 2024 · Jun 30 | $595.9M | — | 34.6% | $88.1M | $70.9M | — | 4.65 | $77.5M | $96.4M | −$18.9M | Jul 31 |
| Q1 2024 · Mar 31 | $589.2M | — | 34.6% | $72.3M | $65M | — | 4.24 | $84.5M | $12.2M | $72.4M | Apr 28 |
| Q4 2023 · Dec 31derived | $585.9M | — | 38.8% | $111.4M | $90.1M | — | 5.91 | $108.6M | $11.8M | $96.8M | Feb 27 |
| Q3 2023 · Sep 30 | $564.5M | — | 35.8% | $86.8M | $75M | — | 4.93 | $28.9M | $11.7M | $17.3M | Nov 1 |
By fiscal year
| Year | Revenue | Gross margin | Operating income | Net income | Net margin | EPS | Op. cash flow | Capex | Free cash flow | Buybacks | Dividends paid |
|---|---|---|---|---|---|---|---|---|---|---|---|
| FY2025 · to Dec 31 | $2.5B | 32.5% | $338.2M | $265.2M | 10.5% | 18.34 | $388.3M | $62.8M | $325.5M | $431.5M | $31.7M |
| FY2024 · to Dec 31 | $2.4B | 35.1% | $366.5M | $302M | 12.4% | 19.89 | $417.5M | $49.5M | $368M | $361.4M | $27.1M |
| FY2023 · to Dec 31 | $2.3B | 35.3% | $340.6M | $272.5M | 12.0% | 17.93 | $330.3M | $56.9M | $273.4M | $67.7M | $23.5M |
| FY2022 · to Dec 31 | $2.1B | 35.8% | $343.5M | $249.6M | 11.7% | 16.53 | $309.9M | $57.3M | $252.6M | $114.5M | $22M |
| FY2021 · to Dec 31 | $2.1B | 36.0% | $343M | $268.6M | 12.6% | 16.85 | $308.6M | $58.7M | $249.9M | $576M | $22M |
| FY2020 · to Dec 31 | $2.1B | 33.7% | $389.7M | $319.5M | 15.4% | 19.48 | $489.3M | $58.8M | $430.5M | $175.6M | $21.1M |
Every number comes from CHEMED CORP's own XBRL-tagged filings with the SEC, not a data vendor. Quarters marked derived are the fiscal year minus the three reported quarters, the same way every data provider computes Q4. Restated figures replace originals as later filings arrive.